Trxade Group Inc (MEDS) — Strategic Asset Allocation Index
Trxade Group Inc (MEDS) has a Strategic Asset Allocation Index of 21.2% as of June 2024. Strategic assets (PP&E of $- plus long-term investments of $2.50 Million) total $2.50 Million, measured against net assets of $11.79 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See MEDS book value for net asset value and shareholders' equity analysis.
SAAI
Strategic Assets
PP&E
Net Assets
Trxade Group Inc Strategic Asset Allocation Index (2014–2022)
This chart shows how Trxade Group Inc's Strategic Asset Allocation Index has evolved across 6 annual periods from 2014 to 2022. As of June 2024, the index stands at 21.2%, representing strategic assets of $2.50 Million against net assets of $11.79 Million USD. See debt-free asset ratio of Trxade Group Inc to measure how much of total assets are equity-financed.
Annual Strategic Asset Allocation Index for Trxade Group Inc (2014–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Trxade Group Inc from 2014 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Trxade Group Inc (MEDS) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 325.8% | $1.12 Million | $1.12 Million | $- | $342.87K | ▲ +290.5 pp |
| 2021 | 35.3% | $1.33 Million | $1.33 Million | $- | $3.77 Million | ▲ +29.0 pp |
| 2020 | 6.3% | $549.77K | $549.77K | $- | $8.68 Million | ▼ -16.2 pp |
| 2019 | 22.5% | $932.70K | $932.70K | $- | $4.14 Million | ▲ +20.8 pp |
| 2018 | 1.8% | $15.01K | $15.01K | $- | $844.67K | ▲ +1.2 pp |
| 2014 | 0.6% | $3.80K | $3.80K | $- | $668.44K | — |